Evidence map›Paper›PMID 37298992›Full record

ArticleMolecules (Basel, Switzerland)2023

Targeting Myeloperoxidase Activity and Neutrophil ROS Production to Modulate Redox Process: Effect of Ellagic Acid and Analogues.

Gilles Degotte, Michel Frederich, Pierre Francotte, Thierry Franck, Thomas Colson, Didier Serteyn, Ange Mouithys-Mickalad

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Vitamin DExperimental biology and medicine (Maywood, N.J.) · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gilles DegotteLaboratory of Medicinal Chemistry, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, 4000 Liège, Belgium.ORCID 0000-0001-6318-4626
Michel FrederichLaboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium.ORCID 0000-0002-0770-9990
Pierre FrancotteLaboratory of Medicinal Chemistry, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, 4000 Liège, Belgium.
Thierry FranckCentre for Oxygen, Research & Development (CORD), Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium.ORCID 0000-0002-4863-805X
Thomas ColsonLaboratory of Medicinal Chemistry, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, 4000 Liège, Belgium.
Didier SerteynCentre for Oxygen, Research & Development (CORD), Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium.
Ange Mouithys-MickaladCentre for Oxygen, Research & Development (CORD), Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium.ORCID 0000-0001-9777-3023
University of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria is an infectious disease caused by a

Indexed as

AntimalarialsMalariaPlasmodiumAntioxidantsEllagic AcidHumansNeutrophilsOxidation-ReductionPeroxidaseReactive Oxygen SpeciesAntimalarialsAntioxidantsEllagic AcidPeroxidaseReactive Oxygen Speciesellagic acidhorseradish peroxidasemalariamyeloperoxidasePMNspolyphenolsreactive oxygen species

Identifiers

PMID37298992
PMCPMC10254444
OpenAlexW4379185355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.